Man Group plc - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 138 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2020. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
Man Group plc ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$1,395,745
+116.7%
54,628
+214.1%
0.00%
+100.0%
Q4 2021$644,000
-32.5%
17,390
-12.9%
0.00%
-33.3%
Q3 2021$954,000
+63.4%
19,959
+15.6%
0.00%
+50.0%
Q2 2021$584,000
-25.9%
17,265
-9.5%
0.00%
-33.3%
Q1 2021$788,000
+54.8%
19,076
+62.5%
0.00%
+50.0%
Q4 2020$509,000
-0.6%
11,738
-1.6%
0.00%0.0%
Q3 2020$512,00011,9240.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q4 2020
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders